At a Glance
The era of easy fertilizer margins is officially over, and Coromandel International (CIL) is frantically digging its own moat. The company recently announced the commissioning of its Kakinada acid plants, a massive ₹ 1,100 crore investment designed to curb its dangerous addiction to imported raw materials. This isn’t just a expansion; it is a desperate tactical pivot to survive in a market where the government’s Nutrient Based Subsidy (NBS) rates are no longer fully compensating for skyrocketing input costs.
While the headline revenue for the quarter grew to ₹ 6,004 crore, up 20.4% YoY, the bottom line tells a far more violent story. Net Profit crashed by 42.5%, tumbling to ₹ 175 crore. The market, rightfully spooked, has wiped nearly 13.8% off the stock price over the last year. Investors are watching a high-stakes race: Can the efficiency gains from backward integration outrun the brutal inflation in Phosphoric acid and Sulphur prices?
The red flags are waving in the wind. Debtor days have spiked from 30 to 49 days, and the company is sitting on a total liability pile of ₹ 24,503 crore, a staggering increase from previous years. The Phosphoric acid benchmark recently jumped from $1,250 to $1,290, and with the Middle East conflict disrupting 75-80% of ammonia imports, Coromandel’s “adequate liquidity” is being tested by significant Letter of Credit (LC) payments due in the coming months.
Is this a strategic masterstroke or a massive capex trap? Management is doubling down, promising that the Kakinada plant will boost EBITDA per ton to ₹ 6,500. However, with the Price to Earning (P/E) ratio sitting at 28.4—well above the Industry P/E of 19.2—there is zero room for error. The company is trading at a premium while its profit growth is effectively flat over a three-year horizon.
Introduction
Coromandel International is the undisputed heavyweight champion of the private phosphatic sector in India, but the ring is getting smaller. Part of the Murugappa Group, this agri-giant handles everything from complex fertilizers and crop protection to high-tech drones. They operate a massive network of 1,113 retail stores and serve over 3 million farmers.
The business is split between Crop Nutrition (roughly 85-89%) and Crop Protection (11-15%). While the nutrition side deals with the volatility of government subsidies and global commodity prices, the crop protection side is the high-margin “growth engine” that management hopes will eventually balance the scales.
In FY26, the company faced a perfect storm. Late monsoons damaged crops in the South, specifically hitting the high-value chilli and grape segments, which are bread-and-butter for CIL’s premium products. Simultaneously, the Indian Rupee depreciated by 7%, making every ton of imported raw material significantly more expensive.
Despite these headwinds, Coromandel is not playing defense. They are aggressively expanding their Mancozeb capacity (a core fungicide) and integrating NACL Industries to build a technical manufacturing powerhouse. They are also betting big on Nano DAP, claiming market leadership in a segment that could theoretically revolutionize fertilizer application.
Business Model – WTF Do They Even Do?
Think of Coromandel as a specialized “dietician” for Indian soil, but one that is heavily regulated by the government. They don’t just sell bags of chemicals; they provide a full stack of “agri-solutions.”
The Fertilizer Factory (The Volume Game)
They are the 2nd largest phosphatic seller in India and the 1st in Single Super Phosphate (SSP). They don’t just sell generic DAP; they specialize in “Unique Grades”—complex NPK mixtures tailored for specific crops. These unique grades now make up 36% of their fertilizer mix, providing slightly better margins than commodity products.
Crop Protection (The Margin Game)
This is
